Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samples

18 Feb 2021

Abstract excerpt

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic, infecting millions of people and causing more than two million deaths. The SARS-CoV-2 Spike glycoproteins mediate viral entry and represent the main target for antibody responses. Humoral responses were shown to be important for preventing and controlling...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Immune responses and vaccinations
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33604922
DOI: 10.1111/trf.16318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samplesPMID 33604922Read ↗

High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samplesSemantic proximity Read ↗

Decline of humoral responses against SARS-CoV-2 Spike in convalescent individualsSemantic proximity Read ↗

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 InfectionSemantic proximity Read ↗

Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralizationSemantic proximity Read ↗

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read ↗

Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 <i>In Vitro</i> Virus Neutralization in Convalescent PlasmaSemantic proximity Read ↗

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationSemantic proximity Read ↗

SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody DynamicsSemantic proximity Read ↗

Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 InfectionSemantic proximity Read ↗

Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 InfectionSemantic proximity Read ↗

Functional Antibodies in COVID-19 Convalescent PlasmaSemantic proximity Read ↗

Changes of Humoral Immunity Response in SARS-CoV-2 Convalescent Patients over 8 monthsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.